BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19522698)

  • 41. Role of systemic chemotherapy in metastatic cervical cancer.
    Hogg R; Friedlander M
    Expert Rev Anticancer Ther; 2003 Apr; 3(2):234-40. PubMed ID: 12722882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy: results from a single institution.
    Khalil J; El Kacemi H; Afif M; Kebdani T; Benjaafar N
    Arch Gynecol Obstet; 2015 Nov; 292(5):1091-9. PubMed ID: 25914074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autophagy in cervical cancer: an emerging therapeutic target.
    Pandey S; Chandravati
    Asian Pac J Cancer Prev; 2012; 13(10):4867-71. PubMed ID: 23244072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
    Goncalves A; Fabbro M; Lhommé C; Gladieff L; Extra JM; Floquet A; Chaigneau L; Carrasco AT; Viens P
    Gynecol Oncol; 2008 Jan; 108(1):42-6. PubMed ID: 17980406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Strategies for Multimodality Therapy in Treating Locally Advanced Cervix Cancer.
    Verma J; Monk BJ; Wolfson AH
    Semin Radiat Oncol; 2016 Oct; 26(4):344-8. PubMed ID: 27619255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacotherapy of cervical cancer.
    Legge F; Fuoco G; Lorusso D; Lucidi A; Borriello M; Pisconti S; Scambia G; Ferrandina G
    Expert Opin Pharmacother; 2010 Aug; 11(12):2059-75. PubMed ID: 20642372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The management of locally advanced cervical cancer.
    Naga Ch P; Gurram L; Chopra S; Mahantshetty U
    Curr Opin Oncol; 2018 Sep; 30(5):323-329. PubMed ID: 29994902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cervical cancer.
    Moore DH
    Obstet Gynecol; 2006 May; 107(5):1152-61. PubMed ID: 16648423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular targeted agents combined with chemo-radiation in the treatment of locally advanced cervix cancer.
    Herrera FG; Vidal L; Oza A; Milosevic M; Fyles A
    Rev Recent Clin Trials; 2008 May; 3(2):111-20. PubMed ID: 18474021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging drugs for cervical cancer.
    Dueñas-Gonzalez A; Cetina L; Coronel J; Cervantes-Madrid D
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):203-18. PubMed ID: 22530838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma.
    Yang PM; Chou CJ; Tseng SH; Hung CF
    Oncotarget; 2017 Jul; 8(28):46145-46162. PubMed ID: 28526810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical review of neoadjuvant chemotherapy followed by surgery for locally advanced cervical cancer.
    Colombo N; Peiretti M
    Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S47-8. PubMed ID: 21053527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breaking the DNA damage response to improve cervical cancer treatment.
    Wieringa HW; van der Zee AG; de Vries EG; van Vugt MA
    Cancer Treat Rev; 2016 Jan; 42():30-40. PubMed ID: 26643553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer.
    Loizzi V; Cormio G; Vicino M; Selvaggi L
    Gynecol Obstet Invest; 2008; 65(2):96-103. PubMed ID: 17878736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
    Marquina G; Manzano A; Casado A
    Curr Oncol Rep; 2018 Apr; 20(5):40. PubMed ID: 29611060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy for recurrent cervical cancer.
    Pectasides D; Kamposioras K; Papaxoinis G; Pectasides E
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol and Cervical Cancer: A New Therapeutic Option.
    Shafabakhsh R; Reiter RJ; Aschner M; Mirzaei H; Asemi Z
    Mini Rev Med Chem; 2023; 23(2):159-169. PubMed ID: 35088669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacotherapy options for locally advanced and advanced cervical cancer.
    Dueñas-González A; Cetina L; Coronel J; Martínez-Baños D
    Drugs; 2010 Mar; 70(4):403-32. PubMed ID: 20205484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global strategies for the treatment of early-stage and advanced cervical cancer.
    Dueñas-González A; Campbell S
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):11-7. PubMed ID: 26626039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond angiogenesis blockade: targeted therapy for advanced cervical cancer.
    Eskander RN; Tewari KS
    J Gynecol Oncol; 2014 Jul; 25(3):249-59. PubMed ID: 25045438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.